	US 12,116,432 B2
	Curable composition
Ryuji Kawamura, Sakai (JP); Hirofumi Fujii, Sakai (JP); and Satoshi Okuda, Sakai (JP)
Assigned to NITTO SHINKO CORPORATION, Fukui (JP)
Appl. No. 17/782,276
Filed by Nitto Shinko Corporation, Sakai (JP)
PCT Filed Dec. 10, 2020, PCT No. PCT/JP2020/046015 § 371(c)(1), (2) Date Jun. 3, 2022, PCT Pub. No. WO2021/117804, PCT Pub. Date Jun. 17, 2021.
Claims priority of application No. 2019-225772 (JP), filed on Dec. 13, 2019.
Prior Publication US 2022/0396645 A1, Dec. 15, 2022
Int. Cl. C08F 2/50 (2006.01); C08F 136/06 (2006.01); C08F 220/18 (2006.01); C08F 220/20 (2006.01); C08G 18/24 (2006.01); C08G 18/62 (2006.01); C08G 18/73 (2006.01)

CPC C08F 2/50 (2013.01) [C08F 136/06 (2013.01); C08F 220/1811 (2020.02); C08F 220/20 (2013.01); C08G 18/246 (2013.01); C08G 18/6208 (2013.01); C08G 18/73 (2013.01)]

8 Claims

1. A curable composition comprising:

a curable oligomer having, in its molecule, a branched polyolefin structure and a (meth)acryloyl group;

a saturated cycloalkyl (meth)acrylate monomer having, in its molecule, a saturated cyclic hydrocarbon structure and a (meth)acryloyl group;

a saturated chain alkyl (meth)acrylate monomer having, in its molecule, a saturated chain hydrocarbon structure and a (meth)acryloyl group, and

an isocyanate monomer having, in its molecule, one or more isocyanate groups.